Real-time enrollment status for this immunoglobulin a nephropathy (igan) clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 4:32 PM UTC
| NCT Number | NCT07146906 |
| Recruiting Status | Recruiting |
| Condition | Immunoglobulin A Nephropathy (IgAN) |
| Phase | PHASE2 |
| Target Enrollment | 32 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of September 2, 2026: Clinical trial NCT07146906 is currently recruiting participants. This phase2 study for immunoglobulin a nephropathy (igan) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07146906 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07146906 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.